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The lymphotoxin LTa1b2 supports the development
and maintenance of several aspects of spleen struc-
ture, but its significance for marginal sinus (MS)
vascular organization is unclear. We showed here
that, in early postnatal lymphotoxin-deficient mice,
the developing Flk-1+ white pulp vessels failed to
organize or upregulate MAdCAM-1, leading to altered
spatial rearrangement of both thewhite pulp endothe-
lial cells and the smooth muscle actin-expressing
cells. In vitro, MAdCAM-1 directed the reorganization
of LTb receptor+ endothelial cells grown on Matrigel.
LTa1b2 also regulated the maintenance of both
MAdCAM-1 expression and mature MS structure in
adult mice, contributing importantly to normal traf-
ficking of CD11b+ cells in response to bacterial anti-
gens. Together, our studies demonstrate that LTa1b2
and LTb receptor signals control proper development
and maintenance of the mature MS structure and
implicate MAdCAM-1 in the structuring of the MS
endothelial cells that is important for the movement
of immune cells within the spleen.
INTRODUCTION
The spleen is a secondary lymphoid tissue with an important role
in host defense against blood-borne pathogens, particularly
encapsulated bacteria (Bohnsack and Brown, 1986; Ejstrud
et al., 2000; Waghorn, 2001). Cells and particles enter the spleen
through the marginal sinus (MS) and then continue to the marginal
zone (MZ) area, which contains several types of resident immune
cells (i.e., macrophages, MZ B cells, and dendritic cells) that
‘‘sample’’ the blood for foreign antigens (Kraal, 1992; Kraal and
Mebius, 2006; Mebius and Kraal, 2005; Mebius et al., 2004).
Scanning electron microscopy (SEM)ofmicrocorrosion castsof
mouse spleen show that the MS consists of a flattened, intercon-
necting vascular network originating from multiple tubular vessels408 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.that branch off of the central arterioles (Schmidt et al., 1985). The
nature of the endothelium lining the MS is unclear, but the MS
endothelial cells express both ephrinB2, a marker that in other
anatomical sites is restricted to arterial vessels (Gale et al.,
2001; Kraal et al., 1995; Shin et al., 2001; Wang et al., 1998), and
the adhesion molecule MAdCAM-1 (Kraal et al., 1995).
The functional significance of MAdCAM-1 in the spleen is
unknown. Systemic blockade with MAdCAM-1 antibodies does
not appear to alter cell trafficking to the spleen under conditions
that halt trafficking of lymphocytes to mucosal secondary
lymphoid tissues (Kraal et al., 1995). In sphingosine-1-phosphate
(S1P) lysophospholipid receptor S1P3-deficient mice that have
abnormally distributed splenic MS expression of MAdCAM-1
(Girkontaite et al., 2004), the MZ B cells enter the white pulp
(WP) nodules faster in response to LPS than they do in wild-type
(WT) mice. These data suggest that MAdCAM-1 organization
may contribute to proper trafficking of cells from the MZ to the
white pulp.
Proteins of the lymphotoxin (LT) and TNF family play key roles in
establishing secondary lymphoid tissue organization. LTa1b2 and
the LTb receptor (LTbR) deliver essential signals in utero for lymph
node and Peyer’s patch organogenesis (Rennert et al., 1996;
Rennert et al., 1998). LTbR-Ig-transgenic mice and mice treated
passively with the LTbR-Fc indicate that interactions between
LTa1b2 and the LTbR after E17 and during neonatal development
are important forestablishingproper splenicarchitecture (Ettinger
et al., 1996; Mackay et al., 1997; Rennert et al., 1996). The spleens
of adult Lta/, Ltb/, and Ltbr/ mice show absence of follic-
ular dendritic cell (FDC) clusters, failure to segregate T and B cells
into discrete zones, absence of MZ cells, and loss of MAdCAM-1
on the sinus-lining cells (Banks et al., 1995; De Togni et al., 1994;
Fu and Chaplin, 1999; Futterer et al., 1998; Koni et al., 1997).
Tnf/andTnfrsf1a/mice (TNFRIdeficient) have lymph nodes
but show defects in spleen architecture (Neumann et al., 1996;
Pasparakis et al., 1996, 1997). In these mutant mice, WP B cells
form abnormal ‘‘ring-like’’ structures, FDCs are abnormally local-
ized in the MZ (Pasparakis et al., 2000), and the numbers of macro-
phages in the MZ are reduced.
Mice that are deficient in several transcription factors of the
NF-kB family also manifest defective spleen organization.
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or mice deficient in RelB have shown abnormal formation of
MZ and germinal center (GC) structures similar to Ltbr/ mice
(Lo et al., 2006; Weih et al., 2001). In addition, MZ structures and
B cell areas appear absent in alymphoplastic aly/aly mice, which
carry a spontaneous point mutation in the gene encoding NF-kB-
inducing kinase (NIK) (Koike et al., 1996). Map3k14/ mice (NIK
deficient) also display abnormalities in lymph node organogenesis
and splenic architecture similar to those seen in aly/aly and Ltbr/
mice (Yin et al., 2001). Importantly, NIK regulates the transcrip-
tional activity of the NF-kB complex via the alternative pathway
specifically in response to LTbR stimulation (Dejardin et al., 2002;
Matsushima et al., 2001; Smith et al., 2001; Yin et al., 2001).
Although overall spleen architecture is dramatically disturbed
in Lta/ and Ltbr/ mice, studies of MS structure have been
hindered by a lack of appropriate cell surface markers because
LTa1b2 is required for MAdCAM-1 expression. Here, we identi-
fied additional markers that permit specific detection of WP
vascular structures in both WT and LT and TNF family-deficient
mice. Immunostaining of thick spleen sections and imaging of
neonatal mice with confocal microscopy demonstrate that,
during the first week after birth, sinus endothelial cells failed to
upregulate MAdCAM-1 and failed to organize normally at the
edge of the developing WP structures of Lta/ and Ltbr/
mice. These data implicate LTa1b2-dependent signals as critical
for the formation of mature marginal sinus vascular structure. In
vitro, LTbR+ endothelial cells can utilize MAdCAM-1 to reorga-
nize, indicating that MAdCAM-1 may contribute to the normal
MS organization of the developing spleen endothelial cells in
the postnatal period. Furthermore, structural analyses reveal
that continuous LTbR signals were required to maintain normal
MAdCAM-1+ MS organization in adult mice, an organization
that importantly supports the movement of local immune cells
responding to microbial challenge.
RESULTS
Flk-1 Is Expressed on Murine Spleen Marginal Sinus
Endothelial Cells
By investigating antigens that may mark MS cells in an LT-inde-
pendent fashion, we found that Flk-1 (VEGFR-2) was predomi-
nantly expressed in the MS area and on vessels more centrally
located within the WP (Figure 1A). Weak Flk-1 staining could
also be detected on the sinusoidal structures in the red pulp
(RP). VE-cadherin (CD144), similar to PECAM-1 (CD31), was
expressed on vascular endothelial cells in both the WP and
RP. Interestingly, VE-cadherin staining was reproducibly weaker
on MS vessels compared to the high expression seen on RP
vessels (Figure 1B).
Because macrophages can express low amounts of Flk-1, we
compared by confocal microscopy the pattern of expression of
Flk-1 with that of PECAM-1 and MOMA-1, which recognizes the
metallophilic macrophage cells that are located closest to the
MS structure (Kraal and Janse, 1986). Flk-1 colocalized with
PECAM-1 (Figure 1C) and not with MOMA-1 (Figure 1D), demon-
strating that the Flk-1 antibody specifically recognized endothelial
cells in the MS. Most of the MOMA-1+ metallophilic macrophages
were located peripheral to the MS in the MZ, with few MOMA-1+
cells found within the WP areas of naive mice.SMA+ Cell Organization Identifies Distinct Vessels
within the White Pulp
MZ-associated smooth muscle actin (SMA)+ cells have been
documented in rodents and primates (Steiniger and Barth, 2000).
Because ephrinB2 is selectively expressed on the ‘‘arterial’’
vasculature of the spleen WP including vessels in the MS area
(Gale et al., 2001; Shin et al., 2001), we questioned whether
smooth muscle cells were also associated with the MS. SMA
staining in mouse spleen was mostly restricted to the WP areas,
with the exception of the large vessels in the RP (Figures 1E and
1F). Strong SMA staining was observed around the WP central
arterioles. Interestingly, in 20 mm sections of spleen, SMA+ cells
were also detected within the T cell areas and at the MS border.
In order to analyze the distribution patterns of the smooth
muscle and endothelial cells within the WP and at the MS border
in greater detail, we used confocal microscopy and compiled
multiple images to construct a 6 mm thick section (Figure 1G).
With this approach, it was apparent that the central arteriole
and the arterial branching vessels showed the strongest SMA
staining. SMA staining near the MS network appeared to be
present as fibrils localized primarily on the WP side (Figure 1H).
These data show that SMA+ cells form a platform under, rather
than encasing, the MS vessels as they do with the central
arteriole and arterial branching vessels.
LTbR Signaling Is Required for Normal Marginal
Sinus Structure
The structure of the MS has not been well characterized in the
spleens of adult Lta/ and Ltbr/ mice because these mice
lack expression of MAdCAM-1. Staining 20 mm thick spleen
sections with the Flk-1 and SMA antibodies indicated that Flk-1+
VE-cadherin+ endothelial cells were present but did not form a
normal MS structure in Lta/ or Ltbr/mice (Figure 2A). Balogh
and colleagues also observed disturbed MS structure in Ltbr/
mice by using the rat antibody, IBL-7/1, which recognized MS
structures in WT mice (Balazs et al., 2001; Balogh et al., 2007).
However, we observed a few Flk-1+ VE-cadherin+ endothelial
cells scattered around the borders of the WP areas in targeted
animals (see Figure 2, enlarged images). Serial 20 mm thick
sections of spleens of Lta/ and Ltbr/ mice showed SMA+
cells associated with the scattered Flk-1+ cells localized at the
border of the WP nodules. This suggested that some vascular
component with features consistent with an MS structure might
be present. The organization of the SMA+ smooth muscle cells
within the WP was also abnormal in Lta/ and Ltbr/ mice
(Figure 2B), with a larger number of SMA+ cells localized around
the central arteriole structures. This phenotype demonstrated
that LTbR signaling affected the distribution of both endothelial
cells and smooth muscle cells within the WP.
Interestingly, Tnfrsf1a/ mice showed a nearly normal MS
structure with some regional discontinuity in the vascular
network around the WP nodules (Figure 2A). Thus, TNFRI signals
are not required for the presence of an MS vascular border but
may contribute to the complete maturation of these vessels.
To further assay the importance of LTbR signaling, we analyzed
the MS architecture in Map3k14/ mice. In the spleens of
Map3k14/ mice, SMA+ cells showed displacement similar to
that seen in Ltbr/ mice and showed no recognizable MS
vascular structure and no Flk-1+ cells at the borders of the WPImmunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc. 409
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LTa1b2 Controls Spleen Marginal Sinus Structurenodules (Figure 2B). The few vascular structures that could be
identified were found primarily in the centers of the WP (repre-
senting central arterioles) and in the RP areas. These data impli-
cate NIK in the signaling that controls endothelial cell and smooth
muscle cell localization in the MS but also suggest that NIK partic-
ipates in signaling events mediated by other receptors in addition
to the LTbR.
To test whether the few scattered Flk-1+ cells that could be
detected at the borders of the WP nodules in Lta/ mice
Figure 1. Flk-1 Marks Marginal Sinus
Smooth Muscle-Associated Endothelial
Cells in the Mouse Spleen
Frozen sections (10 mm thick) from C57BL/6
spleens (n > 10) were stained with anti-B220
(green) and either (A) anti-Flk-1 (red) or (B) anti-
CD144 (VE-cadherin) (red) (magnification 2003).
In (C) and (D), staining was with anti-Flk-1 (green)
and either (C) anti-PECAM-1 (red) or (D) anti-
MOMA-1 (red). For (E) and (F), spleen sections
were cut at 20 mm and stained with (E) anti-SMA
alone (red) (magnification 1003) or together with
(F) anti-B220 (green) (magnification 2003). For (G)
and (H), staining was with (G) anti-SMA alone
(red) (magnification 1003) or together with (H)
anti-Flk-1 (green) (magnification 6303). For (C),
(D), (G), and (H), confocal microscopy was used
to compile a series of Z stack images to reconstruct
a 6 mm thick section. CA, central arteriole; *, central
arteriole branching vessel; ()), MS connecting
vessels. Similar data were obtained in two addi-
tional experiments.
(Figure 2) were part of the WP or the RP
vessels, we compared the expression of
ephrinB2 in WT and Lta/ mice. In WT
mice, ephrinB2 is specifically expressed
on the WP arterial vessels and also on
the MS vasculature (Figure 3A) (Gale
et al., 2001; Shin et al., 2001). Interest-
ingly, 10 mm thick spleen sections from
Efnb2+/ Lta/mice also show scattered
ephrinB2+ cells at the borders of the
WP nodules in a pattern similar to Flk-1
(Figures 2A and 3B). This suggests that
these peripheral endothelial cells in Lta/
mice are analogous to the MS endothelial
cells of WT animals.
In order to obtain a more detailed
picture of the three-dimensional organi-
zation of the MS endothelial cells, we
cut 120 mm spleen sections with a sliding
microtome, compiled image stacks, and
compared the MS area of part of a WP
nodule in Efnb2+/ Lta+/+ and Efnb2+/
Lta/ mice (Figures 3C and 3D). The
cytoplasmic localization of b-galactosi-
dase activity in Efnb2+/ knockin mice
allowed increased signal-to-noise ratio
for confocal imaging of thick spleen
sections; however, similar results were
obtained with the Flk-1 antibody (data not shown). The branching
arterial (BA) vessels in Efnb2+/ mice bifurcate repeatedly
through several orders until they form the complex network of
interconnecting vascular channels that constitute the MS
(Figure 3C). In some areas (see rotating images in Figures S1
and S2 available online), the sinus endothelium appears flat-
tened in a fashion similar to the structures observed in the
SEM microcorrosion casts obtained by Schmidt et al. (1985).
Similar structural features have been shown with intravital
410 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.
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LTa1b2 Controls Spleen Marginal Sinus StructureFigure 2. LTbR Signaling Supports the Organization of Endothelial and Smooth Muscle Cells in the Marginal Sinus
Frozen sections (20 mm thick) from spleens (nR 5) of the indicated mouse strains were stained with (A) anti-Thy1.2 (brown), either anti-Flk-1 (blue, top panels) or
anti-CD144 (VE-cadherin) (blue, bottom panels), (B) anti-Thy1.2 (green), and anti-SMA (red) (magnification 2003). Inset images show magnified areas highlighting
the Flk-1+ and CD144+ structures at the periphery of white pulp areas in the gene-targeted mice.microscopy (Grayson et al., 2001). Distinct gaps in the MS
vasculature were detected, appearing well positioned to permit
movement of cells between the central WP and the more periph-
eral MZ. These key features of the MS structure were all
abnormal in Efnb2+/ Lta/ mice (Figure 3D), with a loss of
80% of the MS vascular region (Figure 3E). The MS ephrinB2+
endothelial cells in the LTa-targeted animals have a thin, tubular
shape similar to that of the branching arterial vessels and do not
appear to have the extensive interconnections or flattened struc-
tures typical of the MS. Thus, LTa1b2 and LTbR signals are
crucial for the proper organization of the MS vascular structure.
LTa1b2 Dictates Proper MS Development during
the First Week of Life
The absence of normally complex MS structures in adult Lta/
(Figures 2 and 3) and Ltbr/ mice (data not shown) indicated
that this signaling pathway is required for the development of
the MS. Balogh and colleagues used rat antibodies to mouse
spleen antigens to observe that, between birth and 1 week of
age, distinct RP and WP areas formed and that the IBL-7/1
antigen became specifically localized at the developing sinus
area, indicating that the early postnatal period was crucial for
spleen vascular development (Balazs et al., 2001; Balogh
et al., 2007). To determine when the MS endothelial and smooth
muscle cells participate in the formation of a mature MS struc-
ture, we followed the appearance and distribution of these cells
during early postnatal development of the spleen by using the
Flk-1 and SMA antibodies (Figure 4A). WT spleen on day 1 had
vascular structures that could not yet be distinguished as specif-
ically RP or WP anlagen (data not shown).
Development of discrete WP and RP vascular structures and
influx of lymphocytes occurred rapidly after birth. By day 3, largenumbers of B220+ cells had entered the spleen. In addition,
SMA+ cells were found around centrally localized structures
that are likely arborizing central arterioles. The majority of Flk-1+
cells were found in the developing RP areas. At this same time,
small numbers of Flk-1+ cells started to congregate around
the edge of the B cell clusters in the developing WP areas
(Figure 4A).
Within the next 2 to 4 days, the pattern of expression of the
SMA+ and Flk-1+ cells changed. The SMA+ cells were more
widely distributed within the WP areas. The Flk-1+ cells were
no longer concentrated in the RP areas but had come together
to form a border around the clusters of B cells in the developing
WP areas. At that time, the developing Flk-1+ MS was still not
a mature structure, and B cells had not achieved a follicular orga-
nization. By 1 week after birth, the developing MS of the spleen
consisted of clusters of Flk-1+ vessels (Figure S3).
By 2 weeks after birth, the clusters of B cells and T cells had
expanded to form discrete zones, but most of the SMA+ cells
were not yet associated with the Flk-1+ cells in the MS. In addi-
tion, the MS structure at that time was not as tightly organized as
it was in the adult tissue. The distribution of the Flk-1+ cells in the
MS at 2 weeks of age appeared less condensed than it did in the
adult. By 3 weeks of age, the MS structure was very similar to
that seen in adult tissue (6 to 8 weeks), with the Flk-1+ cells form-
ing a tight border associated with SMA+ cells around the MS
(data not shown) and numerous branching arterioles terminating
at the MS (Figure S3).
Examination of the spleens of Lta/ mice (Figure 4A) and
Ltbr/ mice (data not shown) during the first weeks after birth
showed defects in several of the developmental events described
above. On day 5, smooth muscle cells in Lta/ spleens showed
no association with the WP, and SMA staining could only beImmunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc. 411
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spleens at day 5 resembled WT spleens at day 1, with the majority
of the Flk-1+ cells still found in the RP areas. By day 7, reorgani-
zation of the Flk-1+ vessels at the periphery of the B cell zones
remained impaired (Figure S3). By day 14, Lta/ B cells still
had not migrated away from the central arteriole structures and,
thus, had not formed discrete B cell follicles. Also, SMA+ cells
were still not widely distributed, and no distinct MS structures
could be found. In adult Lta/ spleens, the smooth muscle cells
in the WP were largely distributed close to the central arteriole
structures and were sometimes found in contact with the few
Flk-1+ cells that separated B cells from the RP. Furthermore, at
3 weeks, the spleens of Lta/ mice had reduced numbers of
branching arterial vessels and connecting sinus vessels com-
pared to WT mice (Figure S3). Our analysis comparing develop-
ment of the MS structure over the first few days after birth showed
differences between WT and Lta/ as early as day 3, suggesting
that some of the critical aspects of LTbR signaling must be
occurring at or prior to this time period.
Figure 3. Disturbed MS Endothelial Cell Network in Lta/ Mice
(A–D) Spleens of Efnb2+/ (A and C) and Efnb2+/ Lta/ (B and D) mice were
cut to yield (A and B) 10 mm or (C and D) 120 mm sections and stained with anti-
b-galactosidase (green) to visualize ephrinB2 expression via the expression of
the in-frame knockin of the LacZ gene. Confocal images were compiled to
yield a 50–60 mm section of spleen, permitting analysis of the 3D structure of
a region of a single white pulp nodule (magnification 2003). Similar data
were obtained by analyzing spleens from five additional pairs of mice.
(E) The percentage of ephrinB2+ and Flk-1+ MS structures per WP area was
quantified from 10 mm sections with a 203 objective.
Graphs show mean + SE (n R 40 WP nodules with R 5 spleens per strain).
Data were compiled from five independent experiments.412 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.LTa1b2 Upregulation of MAdCAM-1 May Participate
in MS Vascular Organization
MAdCAM-1 regulates the homing of lymphocytes to neonatal
lymph nodes (Mebius et al., 1996). To address whether
MAdCAM-1 also contributed to the postnatal population of the
splenic environment, we analyzed the expression and localization
of MAdCAM-1 in the developing neonatal spleen. MAdCAM-1
protein was detected in the spleen on postnatal days 3 and 5
in WT, Tnfrsf1a/, Lta/, and Ltbr/ mice (Figures 4B and
4C); however, in Lta/ and Ltbr/ mice, MAdCAM-1 protein
was significantly reduced in spleen at 1 and 2 weeks of age. Inter-
estingly, in the WT and mutant strains on day 3, MAdCAM-1
expression was localized to the RP vessels (Figure 4D). By day 5,
MAdCAM-1 expression could be detected in the developing MS
area of WT and Tnfrsf1a/ mice, but not in that of Ltbr/ mice.
On day 7, MAdCAM-1 expression in WT and Tnfrsf1a/ mice
was predominantly in the MS area, whereas residual MAdCAM-1
protein in Ltbr/ mice was localized to the large draining
vessels in the RP. Tnfrsf1a/ mice had a similar distribution
of MAdCAM-1 at the MS border compared to WT mice but
showed reduced expression. On day 14, MAdCAM-1 expression
in Tnfrsf1a/ mice was also reduced and appeared less contig-
uous compared to WT mice, suggesting that MS structures
require TNFRI signals to assume the fully developed adult
organization. In contrast, MAdCAM-1 protein expression at the
MS border was completely lost in Ltbr/ mice at all periods of
neonatal development analyzed. Because total spleen cellularity
was similar in WT and Ltbr/ mice, these data suggest that
LTbR-dependent neonatal expression of MAdCAM-1 at the
developing MS contributes primarily to the rearrangement of
the Flk-1+ endothelial cells and to the formation of a properly
organized MS vasculature. Additionally, MS formation early in
neonatal development proceeded independently of TNFRI, but
signaling through this receptor appears to play an important
role in completing MS maturation during the transition to adult life.
LTbR+ Endothelial Cells Demonstrate
MAdCAM-1-Dependent Reorganization
Because splenic vascular cells require LT signals for reorganiza-
tion during development, we questioned whether endothelial
cells may be receiving a direct signal via the LTbR. Interestingly,
LTbR protein appeared to be expressed by stromal-type cells
throughout the spleen and also localized on cells in the marginal
sinus area (Figure 5A). Spleen cells isolated with anti-Flk-1 or anti-
CD144 have an endothelial cell phenotype, shown by their ability
to bind acetylated low-density lipoprotein (AcLDL) (Figure 5B)
and to form capillary-like structures on Matrigel (Figure 5C).
These primary splenic endothelial cells (sECs) and the well-
characterized mouse brain endothelial cell line bEnd.3 expressed
the LTbR protein and mRNA (Figures 5D and 5E). Interestingly,
immunoblotting detected two differentially migrating LTbR mole-
cules, with the smaller protein showing strong expression in the
primary splenic endothelial cells.
To assess the role of LTbR signaling in these sECs, we stimu-
lated the Flk-1+ cells isolated from WT or Lta/ mice with either
a control antibody or an agonist LTbR antibody. Unlike the sECs
from WT mice, the cells isolated from Lta/ mice formed fewer
cellular clusters between the capillary-like structures when
plated on Matrigel (Figure 5F, arrows). However, sECs from WT
Immunity
LTa1b2 Controls Spleen Marginal Sinus StructureFigure 4. Lymphotoxin Controls Organization of Flk-1+ Vessels and Expression of MAdCAM-1 during Neonatal Development
(A–C) (A) Frozen sections of spleens from C57BL/6 and Lta/ mice harvested at the indicated ages (nR 5 per strain per time point) were stained with anti-Flk-1
(red), anti-SMA (green), and anti-B220 (blue) (magnification 2003). Expression of MAdCAM-1 protein was analyzed by (B) immunoblotting and (C) ELISA from
extracts of whole spleens (n = 10 spleens per strain per time point) of C57BL/6, Lta/, Ltbr/, and Tnfrsf1a/ mice.
(D) Spleen sections from the indicated mouse strains (n = 10 spleens per strain per time point) harvested on the indicated postnatal days were stained with anti-
MAdCAM-1 (red) and anti-B220 (green).
#p < 0.01 comparing C57BL/6 and Tnfrsf1a/ mice; *p < 0.005 and **p < 0.001 for comparisons between C57BL/6 and Ltbr/ mice; fp < 0.001 for comparison
between Tnfrsf1a/ and Ltbr/ mice. Graphs show mean + SE.and Lta/ mice stimulated with anti-LTbR reorganized to form
larger areas densely populated with endothelial cells compared
to sECs treated with control antibody.To directly test the ability of MAdCAM-1 to participate in endo-
thelial cell reorganization, we transfected bEnd.3 cells with
a FLAG-tagged MAdCAM-1 expression vector in which theImmunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc. 413
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LTa1b2 Controls Spleen Marginal Sinus StructureFigure 5. Endothelial Cells Express the LTbR and Utilize MAdCAM-1 to Form Specialized Structures on Matrigel
(A–E) (A) Spleen sections (10 mm) from WT mice were stained with anti-LTbR (red) and anti-B220 (green) (n = 3). Endothelial cells isolated from WT spleen (sECs)
with either anti-Flk-1 or anti-CD144 were measured for (B) uptake of AcLDL (green) and (C) observed for formation of tube-like structures on Matrigel (n = 3). sECs
and the bEND.3 cell line were analyzed for expression of (D) LTbR protein and (E) RNA by immunoblotting and RT-PCR.
(F) sECs isolated from WT and Lta/ mice were plated on Matrigel containing a control GST antibody or an agonist anti-LTbR and cultured for 10 days.
(G) bEND.3 cells were transfected with a control pBAP-FLAG vector (expressing bacterial alkaline phosphatase) or 0.1, 0.4, 1, and 4 mg of a pMAdCAM-1-FLAG
vector. The cells were then plated on Matrigel and cultured for 24 hr.
(H) Protein extracts from transfected bEND.3 cells were prepared, and an ELISA was performed to assess MAdCAM-1 protein expression. The graph shows
means + SE.
(I) Transfected bEND.3 cells grown on Anapore filters coated with Matrigel were fixed and frozen in O.C.T., and 8 mm cross-section slices were stained with anti-
FLAG (red) and Hoechst (blue).
Inset images show magnified areas highlighting the EC phenotype and the amount of MAdCAM-1 associated with the Matrigel. Data shown are representative of
three independent experiments.FLAG tag was placed after the cytoplasmic tail (pMAdCAM-
1-FLAG). By using AMAXA nucleofector transfection, we found
that bEND.3 cells show strong FLAG protein expression and
properly localize MAdCAM-1 to the plasma membrane414 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.(Figure S4). Compared to a control vector pBAP-FLAG, bEND.3
cells transfected with pMAdCAM-1-FLAG showed dose-depen-
dent reorganization such that the bEnd.3 cells interacted with the
Matrigel over a larger surface area (Figures 5G and 5H). This was
Immunity
LTa1b2 Controls Spleen Marginal Sinus StructureFigure 6. Intact Marginal Sinus Organization in Adult Mice Is LT Dependent and Supports the Localization of Immune Cells within the Spleen
following Challenge by Bacterial Antigens
(A) C57BL/6 adult mice were treated i.p. with either human IgG1 (huIg) or LTbR-Fc, and spleens were harvested 2 weeks later. Sections (10 mm) were stained with
anti-Flk-1 (blue) and anti-B220 (brown). Similar results were obtained in four additional experiments.
(B) The percentage of Flk-1+ MS structures per WP area was quantified from 10 mm sections with a 203 objective (nR 40 WP nodules from three independent
experiments; graph shows mean + SE).
(C) C57BL/6 mice were treated i.p. with either huIg or LTbR-Fc and 2 weeks later were injected i.v. with 250 mg of TMR-labeled S. aureus bioparticles (red).
Spleens were harvested at 3, 12, or 24 hr after injection with the particles, and sections were stained with anti-CD11b (green). Dashed lines outline WP areas.
(D) The numbers of CD11b+ cells localized in the WP was quantified fromR 40 WP areas from three independent experiments with three to five mice per group.
Graph shows mean + SE. #p < 0.001 comparing control C57BL/6 mice and hulg-treated mice; *p < 0.001 comparing control C57BL/6 mice and LTbR-Fc-treated
mice; fp < 0.001 for comparison between hulg-treated mice and LTbR-Fc-treated mice at the same time interval after treatment.
(E) Expression levels of the indicated cytokines, chemokines, and adhesion molecules were analyzed by immunoblotting. Data are representative of at least three
independent experiments with three to five mice per group.not the result of increased cellular proliferation because the DNA
content from the pMAdCAM-1-FLAG-transfected cultures was
similar compared to that of control transfected cultures (data
not shown). Immunostaining cross-sections of endothelial cells
grown on Matrigel with anti-FLAG indicated that the bEND.3
cells transfected with pMAdCAM-1-FLAG had a more flattened
phenotype and had an increase in membrane-associated
MAdCAM-1 contacting the Matrigel compared to that of control
transfected cells (Figure 5I; see enlarged images). Together,
these data implicate high MAdCAM-1 expression in the flattened
morphology of the MS vasculature and underscore the key role
of LTa1b2 in upregulating MAdCAM-1 and in specifying the
mature MS vascular structure.Ongoing LTbR Signaling Is Required to Maintain
the Adult Marginal Sinus Network
Administration of LTbR-Fc, but not TNFRI-Fc, to adult mice
demonstrated that continuous LTa1b2 signals were required to
maintain fully differentiated spleen architecture (Mackay et al.,
1997); however, because MAdCAM-1 expression on the marginal
sinus was lost in those studies, the organization of the marginal
sinus vasculature could not be assessed. We found that treat-
ment of adult WT mice with a single dose of LTbR-Fc caused
structural changes with a loss of50% of the Flk-1+ MS vascular
region compared to that of human Ig-treated mice (Figures 6A
and 6B). This abnormal phenotype was fully established at
2 weeks after injection of the LTbR-Fc and did not resolve untilImmunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc. 415
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the Flk-1+ endothelium of treated mice reverted to a less complex
pattern, resembling the underdeveloped vascular structures
observed in Lta/ and Ltbr/ mice. Analysis of thicker spleen
sections indicated that, in the absence of LTa1b2 signals, there
were wider gaps in the MS structure compared to those in
controls, suggesting that treatment with the LTbR-Fc caused
a major restructuring of the normally flattened MS vessels
(Figure S5). Thus, continuous LTa1b2 signals were required to
maintain the normal marginal sinus vascular structure.
LT-Dependent MS Maintenance in Adult Mice
Contributes to Proper Cell Localization
Early in the response to thymus-independent (TI) antigens, resi-
dent MZ cells and leukocytes that enter the spleen from the blood
rapidly localize to the MS area (Balazs et al., 2002). To assess
whether normal MS vascular structure is required for the
response to TI antigens, we pretreated WT mice with LTbR-Fc
to disrupt the MS network and then examined the localization
of immune cells in response to intravenous (i.v.) injection of
Staphylococcus aureus (S. aureus) bioparticle antigens. At 3 hr
after injection of the Ag, immune cells were clustered at the
border between the B cell follicles and the MS of LTbR-Fc-treated
mice (Figure 6C). The distribution pattern of these leukocytes was
indistinguishable from the pattern in mice treated with control Ig;
however, the numbers of recruited cells appeared modestly
reduced. This indicated that the initial migration of immune cells
into the MZ area was not profoundly altered by the disruption of
the adult MS vasculature. Later in the response of control animals
(12 and 24 hr after injection ofS. aureus bioparticles), the majority
of CD11b+ cells and other cells laden with the S. aureus antigen
were found localized in the RP where macrophages play an
important role in clearing antigens (Karlsson et al., 2003). Interest-
ingly, at 12 hr and 24 hr after injection of the bioparticles, mice
treated with LTbR-Fc showed abnormal localization of CD11b+
cells in the WP (Figures 6C and 6D). These data suggest that
LTa1b2 signals, in addition to controlling the MS organization,
may also contribute to the trafficking of CD11b+ cells between
the red and white pulp spleen compartments.
To probe the nature of the signals responsible for this
abnormal localization of CD11b+ cells, we also analyzed the
cell localization response of several gene-targeted mouse
strains to challenge with S. aureus bioparticle antigens (Figures
S6A and S6B). In the spleens of control Ig-treated B cell-deficient
(Igh6/) mice, CD11b+ cells are normally distributed in the RP.
In Igh6/ mice treated with LTbR-Fc, i.v. challenge with S.
aureus bioparticles elicited an abnormal distribution of CD11b+
cells similar to that seen in LTbR-Fc-treated, S. aureus biopar-
ticle-challenged WT mice. Thus, B cells are not required for the
LT-dependent localization of CD11b+ cells. Similarly, ICAM-1,
which shows strong expression on the MS endothelium, was
also not required for either the normal S. aureus-driven localiza-
tion of CD11b+ cells at the periphery of the WP or for the redis-
tribution of a portion of these cells into the center of the WP
area. For this experiment, we used the mouse mutant model in
which all isoforms of ICAM-1 were absent (Icam1null) (Bullard
et al., 2007).
Intravenous challenge with S. aureus antigens induced upre-
gulation of the TNF and LTb proteins in the spleen (Figures 6E,416 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.immunoblot, and S6C, ELISA). This increased expression of
LT could not, however, restore the reduced expression of the
MAdCAM-1 and CXCL13 proteins in WT mice that had been pre-
treated for 2 weeks with LTbR-Fc. Because Igh6/ and Rag1/
mice also manifest strongly reduced expression of CXCL13 (Ngo
et al., 1999) but appear to have a normal MS (Figure S7), the
reduction in CXCL13 that is observed in mice that have been
treated with LTbR-Fc appears not to contribute to the changes
in MS structure that are induced by treatment with this blocking
reagent. We suggest, therefore, that the CD11b+ cell phenotype
observed following treatment with LTbR-Fc might be a result of
the loss of the expression of MAdCAM-1 at the MS border,
leading to disrupted MS endothelial structures and consequent
abnormal localization of CD11b+ cells from the MZ to the WP.
DISCUSSION
Vascular endothelial cells in different structural compartments of
the mouse spleen can be distinguished based on their selective
expression of specific surface antigens. Here, we found that
VE-cadherin and PECAM-1 were expressed broadly on splenic
endothelial cells in both the RP and the WP areas, whereas
MAdCAM-1, ephrinB2, and Flk-1 were predominantly expressed
by the endothelial cells of the MS. The pattern of Flk-1 expression
was very similar to that reported for the molecularly undefined
IBL-7/1 antigen (Balazs et al., 2001; Balogh et al., 2007), suggest-
ing that the Flk-1+ cells of the MS may also express the IBL-7/1
antigen. The Flk-1 antigen is particularly valuable for analysis of
the development of the normal spleen MS structure because,
unlike the prototypic MS marker MAdCAM-1, its expression is
not dependent on the LTa1b2 heterotrimer.
By using Flk-1, we observed that LTa1b2 was a key signal for
the establishment of normal MS structure in the postnatal period
(summarized in Figure S8). The requirement for LTa1b2 signaling
was seen as early as day 3 after birth. In either Lta/, Ltbr/, or
LTbR-Fc-treated mice, the proper organization of the endothelial
cells and smooth muscle cells that form a mature MS endothelial
network was disturbed. The cellular source(s) of the LTa1b2 that
drives MS development and maintenance remain undefined. We
have established that the LTa1b2 signal on cells of the lympho-
cyte lineage was not sufficient. Furthermore, spleens from
Rorc(gt)/ mice, which are congenitally deficient of lymphoid
tissue inducer cells (LTi) (Eberl et al., 2004), and neonatal WT
mice treated with anti-CD4, which depletes LTi, showed normal
MS organization (data not shown). Thus, the LTa1b2 signal is
likely delivered by a nonlymphocyte bone marrow-derived cell,
an immature lymphocyte, or a nearby nonhematopoietic lineage
cell such as a neighboring endothelial cell. We have also demon-
strated that primary mouse splenic endothelial cells and the
bEnd.3 cell line expressed the LTbR and that downstream
LTbR signals, such as the upregulation of MAdCAM-1, can
contribute to their reorganization. Together, our data suggest
that LTbR-dependent MAdCAM-1 expression on the splenic
marginal sinus endothelium may act to assist in the development
and maintenance of the complex MS vasculature, helping to
signal its differentiation into a flattened endothelium that controls
the normal distribution and trafficking of specific immune cells
between the different splenic compartments.
Immunity
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permitted us to compile three-dimensional images of the spleen
vasculature, enabling us to identify unique features of the mouse
MS. In particular, we showed that the MS endothelial structures
did not completely surround the WP nodules, but instead they
formed a complex network of vascular channels, with flattened
surfaces and multiple gaps. The structure of the MS suggests
that it may be adapted to reduce the rapid rate of blood flow
from the central arteriole, thereby allowing for enhanced interac-
tion between resident MZ immune cells and antigen in the blood.
Furthermore, the open spaces between the interconnecting
MS vessels may allow for strategic positioning of macrophage
and dendritic cell processes to assist in their interactions with
blood-borne antigens. We found that administration of LTbR-
Fc to adult mice suppresses MAdCAM-1 expression, MS organi-
zation, and the normal localization of CD11b+ cells that are
usually exclusively in the RP following i.v. challenge with bacte-
rial antigens. Similarly, S1pr3/mice (S1P3 deficient) mice have
disorganized MAdCAM-1 expression at the MS and showed
faster migration of MZ B cells into the WP in response to LPS
compared to that of WT (Girkontaite et al., 2004). Together, these
data suggest that appropriate localization of immune cells in the
WP depends on the normal organization of the MS vessels.
LT and TNF family members also play key roles in maintaining
the resident immune cells that are present in the MZ area. The
adhesion molecules ICAM-1 and VCAM-1 play a role in the reten-
tion of MZ B cells within this compartment (Lu and Cyster, 2002),
with expression of ICAM-1 and VCAM-1 on the MS endothelium
controlled by signals delivered through the LTbR. By using
ELISA and immunoblot, we found that expression of ICAM-1
and VCAM-1 protein, although reduced by treatment with the
LTbR-Fc in adult mice, could be upregulated in response to
bacterial antigens that induce signaling via TNF and LTa1b2. In
comparison, expression of MAdCAM-1 protein was dramatically
suppressed for up to 3 weeks after treatment with LTbR-Fc, and
expression of the MAdCAM-1 protein was not upregulated by
local signals produced by the TNF or LTa1b2 that is induced by
bacterial antigens. In view of these data, it is possible that LTbR-
dependent expression of MAdCAM-1 acts tomaintain the integrity
of the splenicendothelial structures, therebyaffecting the distribu-
tion of other adhesion molecules on the MS endothelium.
We observed a correlation between the extent of disturbed MS
architecture and the ability to sustain a normal distribution of
macrophages in the MZ in mice that are deficient in certain LT
and TNF family members. For example, Lta/, Ltb/, Ltbr/,
and Map3k14/ mice, which have grossly disturbed MS devel-
opment, all manifest a complete loss of macrophages from their
normal location in the MZ. Tnf/ and Tnfrs1a/ mice, on the
other hand, which retain substantial MS structure, show instead
reduced numbers of macrophages that maintain an apparently
normal distribution in the MZ (Banks et al., 1995; De Togni
et al., 1994; Futterer et al., 1998; Pasparakis et al., 2000). As
demonstrated in this paper, the failure of MAdCAM-1 upregula-
tion and of reorganization of Flk-1+ vessels during postnatal
development in the spleens of Lta/ and Ltbr/ mice leads to
a profound loss of a normal complex MS endothelial cell network
in adult animals. In contrast, MAdCAM-1 expression, although
reduced in intensity, was present in the developing spleens of
Tnf/ and Tnfrsf1a/ mice. As postnatal spleen developmentprogressed in these TNF- and TNFRI-targeted mice, expression
of MAdCAM-1 on the MS remained reduced. In adult mice of
these strains, however, MAdCAM-1 was dramatically sup-
pressed, with few MAdCAM-1+ cells (which may represent
residual FDCs) found in the marginal zone. Therefore, the
substantial reduction of MAdCAM-1 expression in adult spleens
of Tnf/ and Tnfrsf1a/ mice may contribute to their irregular
MS phenotype. The association between the failure of macro-
phage localization to the MS in Lta/ and Ltbr/ mice and the
profound loss of MS structural complexity in these strains,
together with the less severe reduction in MS macrophages and
only a partial MS structural defect in Tnf/ and Tnfrsf1a/
mice, supports our hypothesis that the proper organization of
this unique vascular structure directly affects the positioning
and/or numbers of resident immune cells in the MZ area.
Our studies demonstrate that interactions between LTa1b2 and
the LTbR, both during the neonatal period and in adult mice,
regulate MAdCAM-1 expression and normal MS organization.
In vitro, endothelial cells utilize LTbR signals and MAdCAM-1
expression to reorganize and form flattened structures, impli-
cating MAdCAM-1 as a mediator of the development and main-
tenance of a normal MS network. Experiments that use in vivo
treatment with an MAdCAM-1 mAb (MECA-367) that blocks
adhesive interactions withb7 integrins either alone or in combina-
tion with a blocking VCAM-1 mAb (data not shown) did not alter
the normal pattern of MS vascular development. Furthermore,
Itgb7/ mice (integrin b7 deficient) appear to have a normal
MZ structure (Lu and Cyster, 2002). Together, these studies
suggest that the N-terminal Ig domain of MAdCAM-1 (the molec-
ular target of the MECA-367 mAb), which typically interacts with
the integrin a4b7, does not contribute to MS organization. Our
in vitro data show that MAdCAM-1 localizes to the plasma
membrane at the apical and basal surfaces of the cell and,
thus, may be in tight association with the extracellular matrix
in vivo. Therefore, MAdCAM-1 may play a central role in the
establishment of the normal MS network by using either another
N-terminal Ig domain or its mucin domain, which is physically
distinct from the MECA-367 epitope. Future studies with trans-
genic and gene-targeted mice affecting selective domains of
MAdCAM-1 will be required to determine the molecular details
of how this adhesion molecule contributes to the establishment
and maintenance of mature MS organization.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J, Igh6/,Rag1/, and Tcrb/Tcrd/mice (Jackson Labs); Il15/
mice (Taconic); and Efnb2+/ (Wang et al., 1998), Efnb2+/ X Lta/ (129/
C57BL/6), Lta/ (C57BL/6) (De Togni et al., 1994), Tnfrsf1a/ (Pasparakis
et al., 1997), Ltbr/ (Futterer et al., 1998), Map3k14/ (129/SvEv) (Yin et al.,
2001), and Icam1null mice (Bullard et al., 2007) were housed in specific path-
ogen-free facilities at Washington University and at the University of Alabama
at Birmingham. Adult mice were used at 6 to 10 weeks of age. Frozen spleen
from an Rorc(gt) mouse was provided courtesy of D. Littman (Eberl et al.,
2004). Animal use was approved by the Institutional Animal Care and Use
Committees of Washington University and the University of Alabama at
Birmingham.
Tissue Preparation
Spleens processed for conventional two-dimensional imaging were
embedded in O.C.T. Compound (Tissue-Tek) and frozen with 2-methyl butaneImmunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc. 417
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onto glass slides, dried, and fixed in cold acetone for 10 min prior to storage
at 20C. Sections used for staining with an anti-b-gal antibody were fixed
in 4% paraformaldehyde (PFA) for 5 min at room temperature and then in
cold acetone for 5 min. Sections requiring quenching were incubated with
0.3% H2O2 in PBS for 3–5 min. All immunostaining steps were performed at
room temperature.
Spleens processed for thick section and three-dimensional imaging were
fixed in 2% PFA, washed in PBS, and then cushioned in 30% sucrose. Whole
tissue was then frozen in M1 matrix medium (ThermoShandon) on the chilled
stage of a sliding microtome (American Optical Corp., model 860). Tissue
sections were cut at 120 mm, placed in cold PBS, and permeabilized with
cold acetone (–20C) prior to antibody staining at 4C.
Reagents for Immunostaining and Immunoblotting
The following reagents were used for immunostaining: anti-Flk1 (VEGF-R2),
anti-MAdCAM-1 (MECA-367), anti-PECAM-1 (CD31), anti-VE-Cadherin
(CD144), anti-B220, anti-IgM, anti-CD33, anti-Thy1.2, anti-CD11b, anti-rat Ig
biotin, and anti-rat IgM PE (BD Biosciences); anti-smooth muscle actin (SMA),
Streptavidin (SA)-Quantum Red, anti-FLAG (M2), and the Fast 3,3-DAB reagent
(Sigma-Aldrich); MOMA-1 antibody (Serotec); SA-Alexa 350, SA-Alexa 488,
anti-rabbit Ig-Alexa 488, anti-fluorescein Alexa 488, Hoechst dye, and the
Prolong Antifade kit (Invitrogen); SA-alkaline phosphatase (AP) (Southern
Biotech); anti-FITC-horse radish peroxidase (HRP) (Dako); anti-b-galactosidase
(Cortex Biochem); anti-LTbR (Santa Cruz); and Vector blue substrate (Vector
Labs). The anti-Flk-1, anti-CD31, anti-b-galactosidase, and anti-MAdCAM-1
(MECA-367) were conjugated with HRP with the Roche Peroxidase Labeling
kit. The HRP-labeled antibodies were visualized with the Tyramide Amplification
System (NEN).
The following reagents were used for immunoblotting: anti-TNF, anti-ICAM-1,
anti-VCAM-1, anti-CXCL13-biotin, and anti-CCL21-biotin (R&D Systems); anti-
MAdCAM-1 (MECA-367, BD Biosciences); anti-b-actin and anti-FLAG (M2)
(Sigma); anti-LTbR (Santa Cruz); peroxidase-conjugated (POD) anti-goat Ig,
POD anti-mouse Ig, POD anti-rat Ig, POD anti-biotin, and POD SA (Roche or
Zymed); biotinylated anti-hamster-Ig (Jackson ImmunoResearch); and the
hamster anti-mouse LTb BBF6 (generously provided by Jeff Browning and
Biogen Idec) (Browning et al., 1997).
Microscopes and Imaging Systems
Images from conventional 10–20 mm thick sections were captured with an
Olympus BX60 microscope with an Optronics cooled CCD digital camera.
The individual fluorescent images were compiled with Adobe Photoshop.
Images of cultured cells were captured with a Zeiss Axiovert 25 microscope
and AxioCam HRc camera. Quantitative analysis of fluorescent images was
performed with the NIH Image J software. Data were expressed as means ±
SE, and statistical analyses were performed with the two-tailed Student’s t
test with two-sample unequal variance.
Images for the colocalization studies were captured with a Zeiss LSM 510
inverted microscope and the Zeiss LSM 5 software. The thick sections and
three-dimensional images were captured at the High Resolution Imaging
Facility at the University of Alabama at Birmingham (UAB) with a Leica DMIRBE
inverted epifluorescence microscope outfitted with Leica TCS NT Laser
Confocal optics (Leica, Inc.; Exton, PA). Optical sections through the z axis
were generated with a stage galvanometer or step motor. Flattened maximum
projections of image stacks were prepared with Leica’s proprietary confocal
imaging software.
In Vivo Administration of Proteins
Adult mice were administered 100 mg of either human IgG1 or LTbR-Fc via i.p.
injection and sacrificed 2 weeks later. The murine LTbR-Fc (constructed with
a human IgG1 Fc fragment) was generously provided by Jeff Browning and
Biogen Idec (Browning et al., 1995), and the control human IgG was purchased
from Sigma. S. aureus bioparticles from Invitrogen (either unlabeled or TMR
labeled) were administered by i.v. injection at 3, 12, and 24 hr before sacrifice.
Immunoblotting
Spleen tissue was disrupted with a Dounce homogenizer (Sigma) in 50:50
T-Per lysis solution (Pierce): RIPA lysis buffer (1% NP40, 50 mM Tris-HCl418 Immunity 30, 408–420, March 20, 2009 ª2009 Elsevier Inc.(pH 8), 150 mM NaCl, 0.5% deoxycholate, and 0.1% SDS) plus 0.1% Protease
Inhibitor Cocktail (Sigma). Cells in suspension or grown on plastic were lysed
with RIPA buffer containing protease inhibitors. Cells were lysed for subcellular
protein fractionation with the S-PEK kit (Calbiochem). The lysates were clari-
fied by centrifugation for 10 min at 4C in a microfuge. Protein content of the
lysates was determined with the BioRad DC protein assay kit, and then
samples were boiled for 5 min in 23 sample buffer (0.5 M Tris-HCl [pH 6.8],
0.4% SDS, 20% glycerol, and 0.3% Bromophenol blue) prior to SDS polyacryl-
amide gel electrophoresis. Proteins were transferred to nitrocellulose (Bio-
Rad), membranes were blocked with 5% nonfat milk in Tris-buffered saline
(TBS), and the blots were probed with the primary antibody in blocking buffer
for 1–2 hr at room temperature or overnight at 4C prior to washing 4 times
for 10 min each with TBS + 1% Tween-20 (TBST). Filters were incubated for
45–60 min with the secondary antibody in blocking buffer, followed by washing
with TBST 4 times for 15 min each, and then developed with a chemilumines-
cence detection kit (Roche).
ELISA
Quantikine colorimetric sandwich ELISA and DuoSet kits were from R&D
Systems. For the MAdCAM-1 DuoSet, we used 1 mg/ml of the MAdCAM-1
(MECA367) antibody from BD Biosciences for coating Immunlon 4HBX plates
(Thermo Scientific) and, if needed, diluted the protein samples in Reagent
Diluent 1 (R&D Systems DY997). Data were expressed as means ± SE, and
statistical analyses were performed with the two-tailed Student’s t test with
two-sample unequal variance.
RT-PCR
RNA was isolated with the RNeasy kit (QIAGEN), and RT-PCR was performed
with the Titan one-step RT-PCR kit (Roche). The primers for LTbR were
GTATGCAGCCGCAGCCAAG (forward) and AGTAGGAGGTACCTGGAGCT
GCC (reverse). The primers for b-actin were TCGTGCGTGACATCAAAGAG
(forward) and TGGACAGTGAGGCCAGGATG (reverse).
Cell Culture
The bEnd.3 mouse brain endothelial cell line, mouse TIMI.4 thymoma line, and
L929 mouse fibroblast cell line (ATCC) were grown in DMEM containing 10%
FBS (Hyclone) and 1% penicillin/streptomycin (Invitrogen). Isolated spleen
endothelial cells were cultured in EGM-2 MV media with growth factor addi-
tives (Lonza) and were supplemented with 1 mmol/l of a smooth muscle cell
inhibitor (Calbiochem). Cells were cultured either on collagen-coated glass
4-well chamber slides (BD Biosciences) for AcLDL-Alexa488 (Invitrogen)
uptake or plated on 200 ml of Matrigel (BD Biosciences) in a 24-well plate at
23 105 cells per well. Cells were also grown on Matrigel-coated Anapore filters
(Fisher), fixed in 2% PFA, washed in PBS, cushioned in 30% sucrose, and then
frozen in O.C.T. Cells treated with antibodies were given either 0.5 mg/ml of
a control hamster Ig (PIP-1D1; anti-glutathione S transferase (Mandik-Nayak
et al., 2001) or agonist hamster anti-mouse LTbR (AF.H6) kindly provided by
Jeff Browning and Biogen Idec (Rennert et al., 1998).
Splenic Endothelial Cell Isolation
Cells from 10 spleens were pooled for each endothelial cell preparation to seed
1 well of a 24-well plate or 1 well of a 4-well chamber slide. The spleens were
first gently broken up between the frosted ends of 2 sterile glass slides to
release the majority of the red and white blood cells, which were then dis-
carded. The remaining mass of tissue was digested with 5 mg/ml Collagenase
D (Roche) and 2 mg/ml DNase I (Sigma) in a 37C water bath for 45 min. The
tissue was gently vortexed for 20 s every 15 min. The digested material was
then passed through a 40 mm filter, and the resulting single cell suspension
was washed in MACS buffer (PBS/2% FBS/2 mM EDTA). The cells were incu-
bated with anti-Flk-1 or anti-CD144 (BD Biosciences), followed by incubation
with anti-rat Ig-MACS beads (Miltenyi Biotec), and were positively selected on
a magnetic MACS column.
Expression Vectors and Transient Transfections
Murine MAdCAM-1 cDNA corresponding to nt 21 to 1243 (NM_013591) was
amplified from bEND.3 mRNA with the Expand High Fidelity Plus PCR system
(Roche). Purified PCR fragments were then subcloned into the p3xFLAG-
CMV-14 vector (Sigma). bEnd.3 cells were transfected with AMAXA Basic
Immunity
LTa1b2 Controls Spleen Marginal Sinus StructureNucleofector Kit Primary Endothelial Cells by using program T-020 according
to the manufacturer’s protocol. bEnd.3 cells were then rested overnight in
60 mm dishes prior to analysis or plating on Matrigel.
SUPPLEMENTAL DATA
Supplemental Data include six figures and two movies and can be found
with this article online at http://www.immunity.com/supplemental/S1074-
7613(09)00113-7.
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